DePuy Synthes Sees Uneven Market Recovery in Second Quarter Company Revenue While the company grew more than +50% compared to 2Q20, the recovery of key segments like knee replacement and spine are lagging. Jul 22, 2021
The Orthopedic M&A Market: Takeaways for 2021 Mergers & Acquisitions The COVID-19 pandemic did little to slow the orthopedic market’s consolidation. We surveyed the orthopedic merger and acquisition market over... Jul 21, 2021
Executives Offer Insight on State and Future of Orthopedic Market and Technology Executive Insights OMTEC held a keynote that delved into the state of the orthopedic market and what lies ahead for volumes and technology. Jun 24, 2021
Orthobiologics Strategy: FDA Issues New Warning about Sales of Unapproved Products Orthobiologics FDA doubled down on its enforcement commitment for Human Cell and Tissue Products after its enforcement discretion ended in May. Jun 22, 2021
Three Questions About the Orthopedic Market in 2Q21 Market Analysis As we near 2Q earnings, we're watching for a barometer of the market's recovery, momentum in M&A as well as the evolution toward digital. Jun 22, 2021
First Case with aap Implantate Silver-Coated Implant Trauma The study is investigating the use of silver-coated implants in complex initial situations, such as chronic bone infections. Jun 18, 2021
Medtronic’s Strong Fiscal Year Close Points Toward Market Recovery Company Revenue The company said its established markets are nearing pre-pandemic sales levels, with ongoing monthly improvement. Jun 01, 2021
MicroPort Orthopedics Optimizing Episodes of Care Company Updates A partnership with PatientIQ will provide an experience that can be specifically tailored to a procedure or a diagnosis. May 27, 2021
Preparing for the Next Big Orthopedic Supply Chain Interruption Actionable Advice OEM and contract manufacturer executives share that businesses can prepare for disruptions by fostering resilient plans, leadership and teams. May 20, 2021
Anika Therapeutics Organic Growth Can’t Offset Viscosupplement Declines Company Revenue The company declined in the mid-single digits due to COVID-related headwinds and inventory stocking declines in its orthobiologics franchise. May 11, 2021